Asset Valuation Throughout the Product Life Cycle

April 25, 2024 at 1:00 PM EST

Whether preparing for a launch or trying to assess commercial strategies throughout the product life cycle, it is necessary to constantly evaluate discounting strategies across all forms of physical and payer channels and across the different types of payers in the market – commercial, Medicare, Medicaid, and government. In this session, we’ll explore strategic and tactical best practices and pitfalls to avoid.

Join Jennifer Sharpe and Reena Patel on April 25 to learn more!

Jennifer Sharpe
Executive Director, Customer Operations

Reena Patel
Senior Director, Channel and Patient Advisory

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article